antiviral activity

Related by string. Antiviral Activity * anti viral . anti virals . antivirals . Antiviral . Antivirals : antiviral medications . stockpiling antiviral drugs . antiviral medication . antiviral drugs Tamiflu . potent antiviral / ACTIVITY . activ ity . Activity : contracting activity N# . DETECTS UNUSUAL ACTIVITY IN . Detects Unusual Activity . Physical Activity * Potent Antiviral Activity *

Related by context. Frequent words. (Click for all words.) 75 antitumor activity 71 tolerability profile 70 pharmacokinetic profile 69 tolerability 68 immunogenicity 67 cytotoxicity 66 efficacy 66 antibody responses 64 Preclinical studies 64 bortezomib 64 pharmacokinetics 64 CYT# 64 pharmacodynamic 63 RDEA# 63 IDX# 62 vitro studies 62 pharmacokinetic 62 immune responses 61 preclinical studies 61 HCV 61 viral load 61 dosing regimens 61 AEZS 61 TMC# [001] 60 pharmacodynamics 60 immunogenic 60 neurotoxicity 60 PMX # 60 monotherapy 59 IMGN# 59 protease inhibitor 59 MGCD# [002] 59 ANA# 59 Phase 1b 58 pegylated interferon 58 safety tolerability 58 dasatinib 58 perifosine 58 antiviral 58 plasma concentrations 57 neutralizing antibodies 57 murine 57 GM CSF 57 HspE7 57 interferon alpha 57 ITMN 57 bioavailability 57 anticancer 57 erlotinib 57 interferon 57 HCV RNA 57 bavituximab 57 lamivudine 57 cytotoxic 56 INCB# [002] 56 ARRY 56 Phase 2a 56 anti angiogenic 56 XL# [003] 56 docetaxel 56 vivo 56 sunitinib 56 rituximab 56 AP# [003] 56 mg dose 56 toxicities 56 sorafenib 56 G CSF 56 MGCD# [001] 56 administered orally 56 preclinical models 56 cytarabine 55 BiovaxID 55 dose regimen 55 small molecule inhibitor 55 dose escalation study 55 maraviroc 55 recombinant protein 55 viral replication 55 elesclomol 55 investigational compound 55 ACTEMRA 55 FTY# 55 Phase Ib 55 Phase IIa clinical 55 gemcitabine 55 Phase 2b study 55 humanized monoclonal antibody 55 Locteron 55 cetuximab 55 HCV infection 55 bevacizumab 54 placebo controlled 54 RG# [001] 54 fusion protein 54 immunological 54 orally administered 54 CUDC 54 fidaxomicin 54 viral loads 54 Phase 2a clinical

Back to home page